Pembroke Management’s Globus Medical GMED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $35.2M | Sell |
408,539
-161,196
| -28% | -$14.5M | 5.09% | 5 |
|
|
2025
Q4 | $49.7M | Buy |
569,735
+7,545
| +1% | +$573K | 5.14% | 2 |
|
|
2025
Q3 | $32.2M | Sell |
562,190
-38,745
| -6% | -$2.23M | 3.19% | 12 |
|
|
2025
Q2 | $35.5M | Buy |
600,935
+67,506
| +13% | +$4.36M | 4.29% | 6 |
|
|
2025
Q1 | $39M | Sell |
533,429
-26,480
| -5% | -$2.19M | 5.69% | 1 |
|
|
2024
Q4 | $46.3M | Sell |
559,909
-8,800
| -2% | -$694K | 5.77% | 1 |
|
|
2024
Q3 | $40.7M | Sell |
568,709
-18,930
| -3% | -$1.34M | 5.19% | 2 |
|
|
2024
Q2 | $40.2M | Sell |
587,639
-38,962
| -6% | -$2.33M | 5.41% | 1 |
|
|
2024
Q1 | $33.6M | Buy |
626,601
+30,694
| +5% | +$1.65M | 3.95% | 5 |
|
|
2023
Q4 | $31.8M | Sell |
595,907
-7,537
| -1% | -$367K | 3.94% | 3 |
|
|
2023
Q3 | $30M | Sell |
603,444
-1,476
| -0.2% | -$82.5K | 4.09% | 1 |
|
|
2023
Q2 | $36M | Buy |
604,920
+58,090
| +11% | +$3.31M | 3.88% | 2 |
|
|
2023
Q1 | $31M | Sell |
546,830
-37,255
| -6% | -$2.39M | 3.39% | 6 |
|
|
2022
Q4 | $43.4M | Sell |
584,085
-6,713
| -1% | -$457K | 4.64% | 1 |
|
|
2022
Q3 | $35.2M | Sell |
590,798
-9,350
| -2% | -$563K | 3.91% | 2 |
|
|
2022
Q2 | $33.7M | Sell |
600,148
-3,255
| -0.5% | -$214K | 3.48% | 4 |
|
|
2022
Q1 | $44.5M | Buy |
603,403
+956
| +0.2% | +$66.5K | 3.72% | 1 |
|
|
2021
Q4 | $43.5M | Buy |
602,447
+1,000
| +0.2% | +$72.6K | 3.19% | 3 |
|
|
2021
Q3 | $46.1M | Buy |
601,447
+1,111
| +0.2% | +$89.2K | 3.47% | 2 |
|
|
2021
Q2 | $46.5M | Sell |
600,336
-14,490
| -2% | -$1.03M | 3.65% | 2 |
|
|
2021
Q1 | $37.9M | Buy |
614,826
+895
| +0.1% | +$56.7K | 3.15% | 4 |
|
|
2020
Q4 | $40M | Buy |
613,931
+123,060
| +25% | +$7.07M | 3.36% | 3 |
|
|
2020
Q3 | $24.3M | Buy |
490,871
+7,585
| +2% | +$391K | 2.65% | 10 |
|
|
2020
Q2 | $23.1M | Sell |
483,286
-5,150
| -1% | -$248K | 2.71% | 9 |
|
|
2020
Q1 | $20.8M | Buy |
488,436
+150,538
| +45% | +$7.44M | 3.3% | 4 |
|
|
2019
Q4 | $19.9M | Sell |
337,898
-31,677
| -9% | -$1.72M | 1.69% | 26 |
|
|
2019
Q3 | $18.9M | Buy |
369,575
+50,538
| +16% | +$2.41M | 2.06% | 23 |
|
|
2019
Q2 | $13.5M | Buy |
+319,037
| New | +$13.9M | 1.42% | 37 |
|
|
2018
Q4 | – | Sell |
-97,750
| Closed | -$5.55M | – | 61 |
|
|
2018
Q3 | $5.55M | Sell |
97,750
-1,650
| -2% | -$86.8K | 0.57% | 54 |
|
|
2018
Q2 | $5.02M | Sell |
99,400
-52,500
| -35% | -$2.74M | 0.51% | 57 |
|
|
2018
Q1 | $7.57M | Sell |
151,900
-84,600
| -36% | -$3.98M | 0.8% | 50 |
|
|
2017
Q4 | $9.72M | Buy |
+236,500
| New | +$8.28M | 1% | 42 |
|
Other funds holding GMED
VCM
VPM
SC
Pembroke Management's GMED Position: Q1 2026 in Review
Pembroke Management reduced its Globus Medical (GMED) stake by 28% in Q1 2026, selling an estimated $14.5M and leaving 408,539 shares worth $35.2M. The position accounts for 5.09% of the portfolio, ranked #5.
Pembroke Management first reported a position in GMED in Q4 2017 and has held it in 32 quarters since. The position peaked at $49.7M in Q4 2025. 602 funds tracked by Wall St. Rank hold GMED as of Q1 2026.
- Pembroke Management held 408,539 shares of Globus Medical worth $35.2M as of Q1 2026.
- Pembroke Management sold 161,196 Globus Medical shares in Q1 2026, an estimated $14.5M.
- Globus Medical made up 5.09% of Pembroke Management's portfolio in Q1 2026, its #5 holding.
- Pembroke Management first reported a position in Globus Medical in Q4 2017 and has held it in 32 quarters since.
- Pembroke Management's Globus Medical position peaked at $49.7M in Q4 2025.
- 602 funds tracked by Wall St. Rank held Globus Medical as of Q1 2026.
Based on Pembroke Management's 13F filing for Q1 2026, filed 14 May 2026.